Why Partner with Pantarhin Pharma?

• Patent-protected innovation with great market potential:
  US and worldwide patents guarantee exclusivity and competitive advantage for our dual-active BELACT® enzyme platform.

• High Market Potential:
  Addressable indications span common (atherosclerosis, cardiac insufficiency) and orphan (familial hypercholesterolemia) diseases. Orphan drug potential enables rapid approval and 7-year exclusivity.

• Flexible Supply Chain:
  API and OEM customers receive GMP-quality enzyme, scalable for pharma, medtech or premium cosmetic integration.

Investment & Growth Opportunities

Patent-protected innovation:
Our exclusive US patents protect the proven Dual-Active BELACT® enzyme technology against competition and create a solid basis for strategic market access.

Comprehensive IP monitoring:
Pantarhin Pharma offers continuous monitoring of relevant patents and market activities in the USA. This enables partners to recognise potential risks at an early stage and adapt business strategies accordingly.

Close dialogue with partners:
We offer investors and OEM/API customers structured access to IP updates and expert advice with the aim of protecting and expanding joint business success in the long term.

Note on business opportunities:
All information on investment and growth opportunities is for information purposes only. Investments or partnerships are made solely on the basis of formal and binding contractual agreements.

Call-to-Action:
Contact us to explore US OEM/API partnership or investment—let’s build your advantage together, activating your expert network as your needs grow.

Partnership Ready – US Collaboration

Seeking Strategic US Partners:
While our US team is being established, we are actively looking for experienced partners to support FDA submissions, clinical studies, and regulatory approvals.

Exclusive Market Opportunity:
Partners can gain equity participation in Pantarhin Pharma and jointly pursue the US market exclusivity and growth potential.

Shared Success Vision:
We aim for long-term collaborations based on transparency, fast decision-making, and scalable business models—empowering our US partners to lead market entry and expansion.

European Expertise, Local Impact:
Backed by our European management’s biotech and regulatory know-how, we provide ongoing strategic guidance and IP support to facilitate US market success.

Legal notice:
The contents of this website are for informational purposes only and do not constitute a binding offer or medical recommendation. BELACT® (D016) is a product under development and not currently authorised for sale or use. Safety, efficacy and approval are subject to ongoing studies and regulatory reviews.